These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 11251894

  • 1. Effect of aggressive prolonged diethylcarbamazine therapy on circulating antigen levels in bancroftian filariasis.
    Freedman DO, Plier DA, De Almeida AB, De Oliveira AL, Miranda J, Braga C.
    Trop Med Int Health; 2001 Jan; 6(1):37-41. PubMed ID: 11251894
    [Abstract] [Full Text] [Related]

  • 2. Ultrastructural analysis of microfilariae of Wuchereria bancrofti obtained from persistent carriers after repeated courses of diethylcarbamazine.
    Alves LC, Cavalcanti MG, Araújo HR, Silva GM, Veras DL, Paiva MH, Brayner FA.
    Micron; 2009 Jan; 40(5-6):659-64. PubMed ID: 19359187
    [Abstract] [Full Text] [Related]

  • 3. Effect of a single dose of diethylcarbamazine, albendazole or both on the clearance of Wuchereria bancrofti microfilariae and antigenaemia among microfilaria carriers: a randomized trial.
    Hoti SL, Pani SP, Vanamail P, Athisaya Mary K, Das LK, Das PK.
    Natl Med J India; 2010 Jan; 23(2):72-6. PubMed ID: 20925201
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The influence of the mass administration of diethylcarbamazine, alone or with albendazole, on the prevalence of filarial antigenaemia.
    Rajendran R, Sunish IP, Mani TR, Munirathinam A, Abdullah SM, Augustin DJ, Satyanarayana K.
    Ann Trop Med Parasitol; 2002 Sep; 96(6):595-602. PubMed ID: 12396322
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Reduction of Wuchereria bancrofti adult worm circulating antigen after annual treatments of diethylcarbamazine combined with ivermectin in French Polynesia.
    Nicolas L, Plichart C, Nguyen LN, Moulia-Pelat JP.
    J Infect Dis; 1997 Feb; 175(2):489-92. PubMed ID: 9203681
    [Abstract] [Full Text] [Related]

  • 9. Histological evidence for adulticidal effect of low doses of diethylcarbamazine in bancroftian filariasis.
    Figueredo-Silva J, Jungmann P, Norões J, Piessens WF, Coutinho A, Brito C, Rocha A, Dreyer G.
    Trans R Soc Trop Med Hyg; 1996 Feb; 90(2):192-4. PubMed ID: 8761588
    [Abstract] [Full Text] [Related]

  • 10. Kinetics of microfilaraemia & antigenaemia status by Og(4)C(3) ELISA in bancroftian filariasis.
    Malla N, Elango A, Pani SP, Mahajan RC.
    Indian J Med Res; 2007 Dec; 126(6):567-74. PubMed ID: 18219085
    [Abstract] [Full Text] [Related]

  • 11. Border and imported bancroftian filariases: baseline seroprevalence in sentinel populations exposed to infections with Wuchereria bancrofti and concomitant HIV at the start of diethylcarbamazine mass treatment in Thailand.
    Bhumiratana A, Koyadun S, Srisuphanunt M, Satitvipawee P, Limpairojn N, Gaewchaiyo G.
    Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):390-407. PubMed ID: 15916046
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of annual single doses of diethylcarbamazine citrate among bancroftian filariasis infected individuals in an endemic area under mass drug administration in Brazil.
    da Silva JSF, Braga C, Duarte FM, Oliveira P, Feitosa Luna C, Marcondes M, Araújo J, Grilis MR, de Souza Melo PFA, Brandão E, Rocha A.
    Pathog Glob Health; 2018 Jul; 112(5):274-280. PubMed ID: 30111259
    [Abstract] [Full Text] [Related]

  • 13. The effect of repeated half-yearly diethylcarbamazine mass treatment on Wuchereria bancrofti infection and transmission in two East African communities with different levels of endemicity.
    Simonsen PE, Meyrowitsch DW, Mukoko DA, Pedersen EM, Malecela-Lazaro MN, Rwegoshora RT, Ouma JH, Masese N, Jaoko WG, Michael E.
    Am J Trop Med Hyg; 2004 Jan; 70(1):63-71. PubMed ID: 14971700
    [Abstract] [Full Text] [Related]

  • 14. The prevalences of Wuchereria bancrofti antigenaemia in communities given six rounds of treatment with diethylcarbamazine, ivermectin or placebo tablets.
    Ramaiah KD, Vanamail P, Pani SP, Das PK.
    Ann Trop Med Parasitol; 2003 Oct; 97(7):737-41. PubMed ID: 14613632
    [Abstract] [Full Text] [Related]

  • 15. The effect of eight half-yearly single-dose treatments with DEC on Wuchereria bancrofti circulating antigenaemia.
    Simonsen PE, Magesa SM, Meyrowitsch DW, Malecela-Lazaro MN, Rwegoshora RT, Jaoko WG, Michael E.
    Trans R Soc Trop Med Hyg; 2005 Jul; 99(7):541-7. PubMed ID: 15869771
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prolonged clearance of microfilaraemia in patients with bancroftian filariasis after multiple high doses of ivermectin or diethylcarbamazine.
    Ismail MM, Weil GJ, Jayasinghe KS, Premaratne UN, Abeyewickreme W, Rajaratnam HN, Sheriff MH, Perera CS, Dissanaike AS.
    Trans R Soc Trop Med Hyg; 1996 Jul; 90(6):684-8. PubMed ID: 9015519
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of a single-dose treatment with 300 mg diethylcarbamazine and a combination of 400 mg albendazole in reduction of Wuchereria bancrofti antigenemia and concomitant geohelminths in Myanmar migrants in Southern Thailand.
    Yongyuth P, Koyadun S, Jaturabundit N, Sampuch A, Bhumiratana A.
    J Med Assoc Thai; 2006 Aug; 89(8):1237-48. PubMed ID: 17048435
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.